Zydus Cadila gets USFDA nod for blood pressure drug
Zydus Cadila today said it has received USFDA approval to market Triamterene and Hydrochlorothiazide tablets, indicated to treat high blood pressure30-06-2018
30-06-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Triamterene and Hydrochlorothiazide Tablets USP.30-06-2018
Zydus Cadila gets USFDA nod for erectile dysfunction drug
Zydus Cadila has received approval from the US health regulator to market Tadalafil tablets, used for treating erectile dysfunction, in the American19-06-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives tentative approval from the USFDA for Tadalafil Tablets USP19-06-2018
Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached the investor presentation to be made to select investors on Monday and Tuesday, June 18 and 19, 2018 at Mumbai.16-06-2018
High base not growth deterrent for Cadila, high launches may drive earning
The stock, which has been trending down due to weak sentiment towards the pharma sector, could provide a good opportunity for investors at current valuations07-06-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
We are pleased to announce that the USFDA inspected the manufacturing facility of our wholly-owned subsidiary, Alidac Pharmaceuticals Ltd., located at SEZ, Ahmedabad from 28th May to 5th June, 2018. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectables for the regulated markets.06-06-2018
Cadila rises 2% on USFDA approval to new drug
This medication is also used for prophylaxis of malaria.04-06-2018
Zydus Cadila gets final nod from USFDA for anti-bacterial drug
Zydus Cadila has received the final approval from the USFDA to market Doxycycline Hyclate Capsules USP, 50 mg and 100 mg02-06-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives final approval from the USFDA for Doxycycline Hyclate Capsules USP02-06-2018